1. |
López R, Castro-Villabón D, Álvarez J, et al. Hepatic angiosarcoma presenting as acute liver failure in young adults. Report of two cases and review of literature[J]. CRCM, 2013,2(8): 439-444.
|
2. |
Arima-Iwasa S, Chijiiwa K, Makino I, et al. A case of hepatic angiosarcoma surviving for more than 16 months after hepatic resection[J]. Hepatogastroenterology, 2007, 54(74): 533-535.
|
3. |
Timaran CH, Grandas OH, Bell JL. Hepatic angiosarcoma: long-term survival after complete surgical removal[J]. Am Surg, 2000, 66(12): 1153-1157.
|
4. |
Locker GY, Doroshow JH, Zwelling LA, et al. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature[J]. Medicine (Baltimore), 1979, 58(1): 48-64.
|
5. |
Lyburn ID, Torreggiani WC, Harris AC, et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances[J]. AJR Am J Roentgenol, 2003, 180(5): 1359-1364.
|
6. |
Tateishi U, Hasegawa T, Muramatsu Y, et al. Hepatic metastases of soft tissue angiosarcoma: CT and Mr imaging findings[J]. Abdom Imaging, 2003, 28(5): 660-664.
|
7. |
Yu R, Zhang S, Hua J. Hepatic angiosarcoma: CT findings[J]. Chin Med J (Engl), 2003, 116(2): 318-320.
|
8. |
Maluf D, Cotterell A, Clark B, et al. Hepatic angiosarcoma and liver transplantation: case report and literature review[J]. Transplant Proc, 2005, 37(5): 2195-2199.
|
9. |
Almogy G, Lieberman S, Gips M, et al. Clinical outcomes of surgical resections for primary liver sarcoma in adults: results from a single centre[J]. Eur J Surg Oncol, 2004, 30(4): 421-427.
|
10. |
Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp,prognosis and treatment[J]. Cancer, 1987, 59(5): 1046-1057.
|
11. |
Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue: a study of forty-four cases[J]. Cancer, 1981, 48(8): 1907-1921.
|
12. |
Abraham JA, Hornicek FJ, Kaufman AM, et al. Treatment and outcome of 82 patients with angiosarcoma[J]. Ann Surg Oncol, 2007, 14(6): 1953-1967.
|
13. |
Mathew P, Vakar-Lopez F, Troncoso P. Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin[J]. Lancet Oncol, 2006, 7(1): 92-93.
|
14. |
Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma[J]. Cancer, 2005, 104(2): 361-366.
|
15. |
D'adamo DR, Anderson SE, Albritton K, et al. PhaseⅡ study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas[J]. J Clin Oncol, 2005, 23(28): 7135-7142.
|
16. |
D'adamo D.R., Keohan M., Schuetze S., et al. Clinical results of a phaseⅡ study of sorafenib in patients (pts) with non-GIST sarcomas (CTEP study#7060)[J]. J Clin Oncol, 2007, 25(18S): 10001.
|
17. |
Kim HR, Rha SY,Cheon SH, et al. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma[J]. Ann Oncol, 2009, 20(4): 780-787.
|